Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC70853Broussochalcone ACAS: 99217-68-2纯度: >97.00%
Broussochalcone A是黄嘌呤氧化酶的抗氧化剂和抑制剂(IC50=2.21 μM),具有清除自由基的活性。
- GC70900TLR7/8 antagonist 2CAS: 2769085-03-0纯度: >99.00%
TLR7/8 antagonist 2(化合物15)是TLR7/8的强效口服活性激动剂,IC50分别为4.9和0.6 nM。
- GC70953α7 nAchR-JAK2-STAT3 agonist 1CAS: 2108714-20-9纯度: 不显示
α7 nAchR-JAK2-STAT3 agonist 1是一种有效的α7 nAchR-JAK2-STAT3激动剂,对一氧化氮(NO)的IC50值为0.32 μM。
- GC70979Anti-inflammatory agent 38CAS: 3032633-42-1纯度: >98.00%
Anti-inflammatory agent 38(化合物23d)是一种有效的Nrf2/HO-1途径抑制剂,对NO的IC50值为0.38 μM。
- GC70987Avacincaptad pegol sodiumCAS: 1491144-00-3纯度: >98.50%
Avacincaptad pegol sodium是一种抗C5 RNA适配体,可抑制补体因子5 (C5)裂解为C5a和C5b。
- GC71123Galectin-8N-IN-1CAS: 2667628-25-1纯度: >98.00%
Galectin-8N-IN-1(化合物19a)是一种强效且选择性的半乳凝素-8N抑制剂,Kd值为1.8μM。
- GC71129Diprovocim-XCAS: 3005274-77-8纯度: >98.00%
Diprovocim-X(化合物35)是一种有效的TLR1/TLR2 (toll样受体1/2)激动剂,hTLR1/TLR2和mTLR1/TLR2的EC50值分别为0.14和0.75 nM。
- GC71144Phytoene desaturase-IN-1CAS: 2765793-54-0纯度: >99.00%
Phytoene desaturase-IN-1是一种有效的八氢番茄红素脱饱和酶(PDS)抑制剂(Kd:65.9μM),通过与Phe301残基的π-π堆积效应。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC70759 | AQX-435 | 1619983-52-6 | >99.00% | |
AQX-435是一种强效的SHIP1磷酸酶激活剂。 | ||||
| GC70768 | BMS-986251 | 2460133-35-9 | 不显示 | |
BMS-986251是一种口服活性和选择性RORγt反向激动剂,RORγt-GAL4的EC50为12 nM。 | ||||
| GC70787 | β-Aminoarteether | 133162-24-0 | 不显示 | |
β-Aminoarteether(SM934游离碱)是一种具有口服活性的青蒿素衍生物。 | ||||
| GC70826 | Guretolimod hydrochloride | - | >98.00% | |
Guretolimod hydrochloride是Toll样受体7(TLR7)激动剂。 | ||||
| GC70853 | Broussochalcone A | 99217-68-2 | >97.00% | |
Broussochalcone A是黄嘌呤氧化酶的抗氧化剂和抑制剂(IC50=2.21 μM),具有清除自由基的活性。 | ||||
| GC70868 | Nrf2 activator-3 | 2766570-23-2 | >98.00% | |
Nrf2 activator-3是一种有效的Nrf2激活剂。 | ||||
| GC70900 | TLR7/8 antagonist 2 | 2769085-03-0 | >99.00% | |
TLR7/8 antagonist 2(化合物15)是TLR7/8的强效口服活性激动剂,IC50分别为4.9和0.6 nM。 | ||||
| GC70937 | Paridiprubart | 2641646-59-3 | >95.00% | |
Paridiprubart(NI-0101)是一种人源化的抗TLR4单克隆抗体。 | ||||
| GC70953 | α7 nAchR-JAK2-STAT3 agonist 1 | 2108714-20-9 | 不显示 | |
α7 nAchR-JAK2-STAT3 agonist 1是一种有效的α7 nAchR-JAK2-STAT3激动剂,对一氧化氮(NO)的IC50值为0.32 μM。 | ||||
| GC70979 | Anti-inflammatory agent 38 | 3032633-42-1 | >98.00% | |
Anti-inflammatory agent 38(化合物23d)是一种有效的Nrf2/HO-1途径抑制剂,对NO的IC50值为0.38 μM。 | ||||
| GC70987 | Avacincaptad pegol sodium | 1491144-00-3 | >98.50% | |
Avacincaptad pegol sodium是一种抗C5 RNA适配体,可抑制补体因子5 (C5)裂解为C5a和C5b。 | ||||
| GC71031 | Nrf2 activator-6 | 2728780-74-1 | 不显示 | |
Nrf2 activator-6四氢异喹啉化合物是Nrf2活化剂。 | ||||
| GC71071 | Polyinosinic acid sodium | 33378-44-8 | 不显示 | |
Polyinosinic acid sodium是聚肌苷酸的钠形式。 | ||||
| GC71072 | NXPZ-2 | 2254492-08-3 | >98.00% | |
NXPZ-2是一种口服活性Keap1-Nrf2蛋白-蛋白相互作用(PPI)抑制剂,Ki值为95 nM,EC50值为120和170 nM。 | ||||
| GC71113 | IL-2-IN-1 | 245747-10-8 | >99.00% | |
IL-2-IN-1是一种有效的IL-2抑制剂,IC50值为1978nM。 | ||||
| GC71119 | UBX1325 | 2271269-01-1 | >98.00% | |
UBX1325是一种促进衰老细胞凋亡的Bcl-xL抑制剂。 | ||||
| GC71123 | Galectin-8N-IN-1 | 2667628-25-1 | >98.00% | |
Galectin-8N-IN-1(化合物19a)是一种强效且选择性的半乳凝素-8N抑制剂,Kd值为1.8μM。 | ||||
| GC71128 | Diclofenac-d4 sodium | 154523-54-3 | >99.00% | |
Diclofenac-d4 sodium是氘标记的双氯芬酸钠。 | ||||
| GC71129 | Diprovocim-X | 3005274-77-8 | >98.00% | |
Diprovocim-X(化合物35)是一种有效的TLR1/TLR2 (toll样受体1/2)激动剂,hTLR1/TLR2和mTLR1/TLR2的EC50值分别为0.14和0.75 nM。 | ||||
| GC71133 | FITC-labeled ODN 1018 sodium | - | >94.00% | |
FITC-labeled ODN 1018 sodium寡脱氧核苷酸是一种TLR-9激动剂。 | ||||
| GC71136 | ODN 2395 sodium | - | 不显示 | |
ODN 2395 sodium是一种C类寡脱氧核苷酸,可用作疫苗佐剂。 | ||||
| GC71137 | ODN 24888 | 1964506-30-6 | 不显示 | |
ODN 24888是鸟嘌呤修饰的抑制性寡核苷酸(INH-ODN)。 | ||||
| GC71144 | Phytoene desaturase-IN-1 | 2765793-54-0 | >99.00% | |
Phytoene desaturase-IN-1是一种有效的八氢番茄红素脱饱和酶(PDS)抑制剂(Kd:65.9μM),通过与Phe301残基的π-π堆积效应。 | ||||
| GC71149 | NIC-0102 | 2806031-94-5 | >98.00% | |
NIC-0102是一种口服活性蛋白酶体抑制剂(pIC50=7.55),其特异性抑制NLRP3炎性囊泡激活。 | ||||
